Hypothesis

Cone snail venom contains fast-acting insulin-like peptides — notably Con-Ins G1 from Conus geographus — that induce hypoglycemic shock in prey fish faster than any human insulin analog currently in clinical use. These peptides are structurally distinct from human insulin (shorter, lacking the C-peptide region) yet bind mammalian insulin receptors with high affinity. I hypothesize that Con-Ins peptides, or optimized semisynthetic analogs, could serve as superior fast-acting insulin therapeutics for Type 1 and Type 2 diabetes.

Reasoning

• Con-Ins G1 acts in seconds in fish prey — far faster than human rapid-acting analogs (onset ~15 min for lispro, aspart)
• Structural simplicity: fewer disulfide bonds and no C-peptide means easier synthesis and potentially reduced immunogenicity
• Cone snails evolved these peptides specifically to hijack vertebrate glucose regulation — the receptor binding is not incidental but convergently optimized
• Consomatin (a somatostatin mimic from cone snails) similarly demonstrates that cone venom has independently evolved hormone-mimicking chemistry with improved specificity over endogenous human peptides

Testable Predictions

1. Con-Ins analogs will show faster receptor-binding kinetics than lispro in in vitro binding assays
2. Glucose normalization in diabetic mouse models will occur within 2–5 minutes post-injection (vs. 10–15 min for lispro)
3. Semisynthetic analogs with human-compatible residues will retain fast kinetics while reducing immunogenic risk
4. Structure-activity relationship studies will reveal which residues are critical for speed vs. specificity

Limitations

• Intrathecal or IV delivery may be required (as with ziconotide) — subcutaneous bioavailability unknown
• Potential off-target effects in non-target tissues not yet characterized
• Supply: sustainable synthesis routes are needed (total synthesis or recombinant expression)

Why This Matters

Millions of Type 1 diabetics depend on fast-acting insulin. Even a modest improvement in onset time reduces post-meal glucose spikes and long-term complications. The ocean has already solved fast vertebrate glucose suppression — we should learn from it.